ConductScience.org, home

Paper20523901

Few and far between: how HIV may be evading antibody avidity.

Klein JS and 1 other. PLoS Pathog, 2010. Cited by 239 papers, by iCite.

Cite this record

ConductScience Library. Few and far between: how HIV may be evading antibody avidity. Papers, record 20523901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20523901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Few and far between: how HIV may be evading antibody avidity.
PubMed
Journal
PLoS Pathog
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
239
iCite
Relative citation ratio, by iCite
4.69
iCite
Revised in PubMed
2021-10-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klein JSJoshua S
2Bjorkman PJPamela J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV AntibodiesMajor topic
HIV InfectionsMajor topic
HIV-1Major topic
AIDS Vaccines
Antibody Affinity
Antibody Specificity
Humans
Mutation
Protein Structure, Quaternary

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Howard Hughes Medical InstituteUnited StatesPubMed

Source PubMed

Download CSV of grants

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118313941Zernike phase contrast electron microscopy of ice-embedded influenza A virus.J Struct Biol2008https://conductscience.org/library/papers/18313941PubMed
216862157Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.Nat Struct Mol Biol2006https://conductscience.org/library/papers/16862157PubMed
319287373Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.Nature2009https://conductscience.org/library/papers/19287373PubMed
416160141Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.J Virol2005https://conductscience.org/library/papers/16160141PubMed
515308718Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.J Virol2004https://conductscience.org/library/papers/15308718PubMed
68627711Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.J Virol1996https://conductscience.org/library/papers/8627711PubMed
717901336Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.Science2007https://conductscience.org/library/papers/17901336PubMed
81386485Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.Virology1992https://conductscience.org/library/papers/1386485PubMed
912634368Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.J Virol2003https://conductscience.org/library/papers/12634368PubMed
1019843556HIV vaccine trial results--an opening for further research.N Engl J Med2009https://conductscience.org/library/papers/19843556PubMed
1118945777Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency.J Virol2009https://conductscience.org/library/papers/18945777PubMed
129371638Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.J Virol1997https://conductscience.org/library/papers/9371638PubMed
1311991960
Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
J Virol2002https://conductscience.org/library/papers/11991960PubMed
1417928656A dynamical study of antibody-antigen encounter reactions.Phys Biol2007https://conductscience.org/library/papers/17928656PubMed
1518842730
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
J Virol2008https://conductscience.org/library/papers/18842730PubMed
1611581389Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.J Virol2001https://conductscience.org/library/papers/11581389PubMed
1717480119Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry.PLoS Pathog2007https://conductscience.org/library/papers/17480119PubMed
1815627210Binding parameters of antibodies: pseudo-affinity and other misconceptions.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15627210PubMed
1912970440Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.J Virol2003https://conductscience.org/library/papers/12970440PubMed
2020357769Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.Nat Struct Mol Biol2010https://conductscience.org/library/papers/20357769PubMed

See all 70 referencesDownload CSV of references

Cited by193

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 239 citations.

PMIDTitleJournalYearIn PapersSource
42806979Antigenic remodeling of the SARS-CoV-2 Spike N-terminal domain links sequence variability to structural reorganization of a neutralizing antibody supersite.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42806979PubMed
42749798Mutational constraints on RSV F and its neutralization by antibodies.Nature2026https://conductscience.org/library/papers/42749798PubMed
42330958Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses.Immunity2026https://conductscience.org/library/papers/42330958PubMed
42069746High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies.NPJ Vaccines2026https://conductscience.org/library/papers/42069746PubMed
42012184Recent advances in HIV-1 envelope-based vaccine designs for guiding broadly neutralizing antibody response.J Virol2026https://conductscience.org/library/papers/42012184PubMed
41993435Human antibodies against West Nile and related orthoflaviviruses.bioRxiv2026https://conductscience.org/library/papers/41993435PubMed
41965897Cryo-ET of IgG bivalent binding on SARS-CoV-2 provides structural basis for antibody avidity.Nat Commun2026https://conductscience.org/library/papers/41965897PubMed
41648420Reconstructing a Missing Link of HIV-1 Assembly: HIV-1 Envelope-Matrix Interactions in a Native Viral Context.bioRxiv2026https://conductscience.org/library/papers/41648420PubMed
41642934Antigen flexibility supports the avidity of hemagglutinin-specific antibodies at low antigen densities.PLoS Pathog2026https://conductscience.org/library/papers/41642934PubMed
41634487Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope.Nat Immunol2026https://conductscience.org/library/papers/41634487PubMed
41583464Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection.Front Immunol2025https://conductscience.org/library/papers/41583464PubMed
41373539Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection.Int J Mol Sci2025https://conductscience.org/library/papers/41373539PubMed
40964353Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.bioRxiv2025https://conductscience.org/library/papers/40964353PubMed
40955274Chimeric antigen receptor T-cell therapy and bispecific antibodies in the treatment of lymphoma for human immunodeficiency virus-infected patients: A systematic review.SAGE Open Med2025https://conductscience.org/library/papers/40955274PubMed
40904452Molecular ingredients of an immunogen for long-lasting IgG.Front Immunol2025https://conductscience.org/library/papers/40904452PubMed
40628289Understanding antibody-target antigen interactions and the avidity effect using mathematical modelling.J R Soc Interface2025https://conductscience.org/library/papers/40628289PubMed
40338637Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein.Elife2025https://conductscience.org/library/papers/40338637PubMed
40285021Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles.Viruses2025https://conductscience.org/library/papers/40285021PubMed
40193609Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40193609PubMed
39746910The molecular reach of antibodies crucially underpins their viral neutralisation capacity.Nat Commun2025https://conductscience.org/library/papers/39746910PubMed

See all 193 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
NDUFB34709PubTator's text mininghttps://conductscience.org/library/genes/4709NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20523901

GET https://conductscience.org/api/papers/v1/20523901/references?page=2